Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

Orphan diseases

  • Outpatient lobar lavage: a novel approach to managing pulmonary alveolar proteinosis
    Chanel Kwok, Kayvan Amjadi
    European Respiratory Journal Sep 2020, 56 (suppl 64) 1200; DOI: 10.1183/13993003.congress-2020.1200
  • Diagnosing alpha-1 antitrypsin deficiency in Romania - first 1000 cases tested
    Ana-Maria Zaharie, Valentin Caius Cosei, Alina Croitoru, Lavinia Davidescu, Joanna Chorostowska-Wynimko, Ruxandra Ulmeanu
    European Respiratory Journal Sep 2020, 56 (suppl 64) 1130; DOI: 10.1183/13993003.congress-2020.1130
  • Multidisciplinary Approach in the Evaluation and Management of Patients with Malignant Pleural Mesothelioma. A Single Center Experience
    Giulia Maria Stella, Claudio Valizia, Laura Saracino, Francesco Agustoni, Emma Pozzi, Pietro Rinaldi, Cristiano Primiceri, Matteo Bosio, Patrizia Morbini, Chandra Bortolotto, Angelo Corsico
    European Respiratory Journal Sep 2020, 56 (suppl 64) 1139; DOI: 10.1183/13993003.congress-2020.1139
  • Different clinical suspect that brings to the diagnosis of alpha1-antitrypsin deficiency
    Stefania Ottaviani, Bruno Balbi, Valentina Barzon, Alice Maria Balderacchi, Alessandra Corino, Davide Piloni, Francesca Mariani, Angelo Guido Corsico, Ilaria Ferrarotti
    European Respiratory Journal Sep 2020, 56 (suppl 64) 995; DOI: 10.1183/13993003.congress-2020.995
  • Fibrosis score predicts mortality in patients with chronic hypersensitivity pneumonitis
    Jieun Kang, Jin Woo Song
    European Respiratory Journal Sep 2020, 56 (suppl 64) 800; DOI: 10.1183/13993003.congress-2020.800
  • Interstitial pneumonia with autoimmune features (IPAF): the relationship between radiological and clinical features
    Victoria Sholomova, Larisa Akulkina, Michael Brovko, Alisa Yanakaeva, Denis Konovalov, Sergey Moiseev
    European Respiratory Journal Sep 2020, 56 (suppl 64) 761; DOI: 10.1183/13993003.congress-2020.761
  • Prevalence and mortality of systemic sclerosis-associated interstitial lung disease (SSc-ILD) using the French national health insurance system (SNDS) database in France
    Mouhamad Nasser, Sophie Larrieu, Loic Boussel, Salim Si-Mohamed, Fabienne Bazin, Sébastien Marque, Jacques Massol, Didier Revel, Francoise Thivolet-Bejui, Lara Chalabreysse, Delphine Maucort-Boulch, Eric Hachulla, Stéphane Jouneau, Vincent Cottin
    European Respiratory Journal Sep 2020, 56 (suppl 64) 805; DOI: 10.1183/13993003.congress-2020.805
  • Consistent effect of nintedanib on reducing FVC decline across interstitial lung diseases (ILDs)
    Francesco Bonella, Toby M. Maher, Vincent Cottin, Claudia Valenzuela, Marlies Wijsenbeek, Florian Voss, Klaus B. Rohr, Susanne Stowasser
    European Respiratory Journal Sep 2020, 56 (suppl 64) 739; DOI: 10.1183/13993003.congress-2020.739
  • A review of patients following a diagnosis of unclassified interstitial lung disease (ILD) at a tertiary centre
    Fiona Thompson, Tim Wallis, Katarina Pontoppidan, Chris Brereton, Eleanor Reid, Benjamin Welham, Mark Jones, Sophie Fletcher
    European Respiratory Journal Sep 2020, 56 (suppl 64) 760; DOI: 10.1183/13993003.congress-2020.760
  • Does excluding subjects with features similar to IPF affect the results of the INBUILD trial of nintedanib?
    Luca Richeldi, Athol U. Wells, Vincent Cottin, Bruno Crestani, Maria Molina Molina, Rainer-Georg Goeldner, Susanne Stowasser, Rozsa Schlenker-Herceg, Yoshikazu Inoue
    European Respiratory Journal Sep 2020, 56 (suppl 64) 740; DOI: 10.1183/13993003.congress-2020.740

Pages

  • Previous
  • Next
  • 1
  • …
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • …
  • 28
  • Acute lung injury and critical care (82)
  • Asthma and allergy (662)
  • CF and non-CF bronchiectasis (278)
  • COPD and smoking (909)
  • Epidemiology, occupational and environmental lung disease (214)
  • Genetics (60)
  • Interstitial and orphan lung disease (497)
  • Lung biology and experimental studies (318)
  • Lung cancer (281)
  • Lung imaging (45)
  • Lung structure and function (303)
  • Mechanisms of lung disease (145)
  • Paediatric pulmonology (394)
  • Pulmonary pharmacology and therapeutics (141)
  • Pulmonary vascular disease (523)
  • Respiratory clinical practice (171)
  • Respiratory infections and tuberculosis (970)
  • Sleep medicine (266)

Custom Text goes here

  • Most Read
  • Twitter
Loading

Tweets by @ERSpublications

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society